Study of Plasma End statin Level in Patients with Acute Myeloid Leukaemia
*Corresponding Author:
Copyright: © 2019 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
![image](https://www.omicsonline.org/images/download-pdf.jpg)
Abstract
Endostatin is a broad spectrum angiogenesis inhibitor and may interfere with the
proangiogenic action of growth factors. Acute Myeloid Leukemia (AML) is an aggressive hematologic malignancy
characterized by accumulation of immature malignant myeloid cells in the bone
marrow and blood due to their clonal proliferation without substantial maturation